RxDoctor Payments DataLook up a doctor →

Daniel Gossett

Neurology with Special Qualifications in Child Neurology · Dallas, TXNPI 1588980072

Payments from drug & device makers

$35,715in general payments, 2019–2025

Across 763 payments — averaging $46.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Immedica Pharma US, Inc.$16K
  • Biomarin Pharmaceutical Inc.$5K
  • UCB, Inc.$2K
  • Ironshore Pharmaceuticals Inc.$1K
  • Natus Medical Incorporated$1K
  • Eisai Inc.$1K
  • plus $10K from 54 others

What the payments were for

  • Speaking & faculty fees$20,04656%
  • Travel & lodging$6462%
  • Food & beverage$14,98242%
  • Education$410%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Immedica Pharma US, Inc.36$15,935
Biomarin Pharmaceutical Inc.9$5,118
UCB, Inc.79$1,511
Ironshore Pharmaceuticals Inc.65$1,092
Natus Medical Incorporated2$1,012
Eisai Inc.54$1,008
Supernus Pharmaceuticals, Inc.66$891
Livanova USA, Inc.27$817
Jazz Pharmaceuticals Inc.33$710
Neurelis, Inc.39$688
Tris Pharma Inc35$556
Corium, LLC22$461
SK Life Science, Inc.18$447
Neos Therapeutics, LP24$432
Sunovion Pharmaceuticals Inc.23$384
Acadia Pharmaceuticals Inc15$343
Aquestive Therapeutics, Inc.19$294
Argenx US, Inc.8$273
Merz Pharmaceuticals, LLC8$256
AbbVie(2 entities)12$239
Takeda Pharmaceuticals U.S.A., Inc.11$238
Adlon Therapeutics L.p.15$212
Sumitomo Pharma America, Inc.11$187
Zogenix Inc.8$180
Neurocrine Biosciences, Inc.6$177
Biohaven Pharmaceuticals, Inc.10$166
Teva Pharmaceuticals USA, Inc.5$164
Aprecia Pharmaceuticals, LLC9$161
Biogen7$141
Ipsen Biopharmaceuticals, Inc5$129
TG Therapeutics, Inc.6$121
AstraZeneca4$86
Catalyst Pharmaceuticals, Inc.5$84
Octapharma USA, Inc.3$74
Grifols USA, LLC3$74
Arbor Pharmaceuticals, Inc.5$65
Amneal Pharmaceuticals LLC3$60
Shire North American Group Inc4$59
Collegium Pharmaceutical, Inc.3$59
Avion Pharmaceuticals3$51
Sanofi2$49
Lundbeck LLC3$48
NS Pharma, Inc.2$47
Travere Therapeutics, Inc.4$46
PTC Therapeutics, Inc.2$43
Cranial Technologies, Inc3$41
ANI Pharmaceuticals, Inc.2$41
Kedrion Biopharma, Inc.2$40
Springworks Therapeutics, Inc.2$35
Biohaven Pharmaceutical Holding Company Ltd.2$32
Sarepta Therapeutics, Inc.2$32
Mallinckrodt Enterprises LLC2$32
Biocodex, Inc.1$30
Aucta Pharmaceuticals, Inc.2$29
Azurity Pharmaceuticals, Inc.1$26
Revance Therapeutics, Inc.1$24
Abbott1$22
Lilly USA, LLC1$21
CSL Behring1$20
Noven Therapeutics, LLC1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,715 in reported general payments places this provider in the 80th percentile of 193 neurology with special qualifications in child neurology providers in Texas.

See all neurology with special qualifications in child neurology providers in Texas

Other neurology with special qualifications in child neurology in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →